Related Experiment Video
Updated: Jun 1, 2026
10:42
A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
Published on: February 27, 2019
Recent advances in nanoparticle formulation of oleanolic acid
Meiwan Chen1, Zhangfeng Zhong1, Wen Tan1
1State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China.
Chinese Medicine
|May 31, 2011
Summary
Oleanolic acid (OA), a natural compound with many health benefits, has limited clinical use due to poor solubility. Nanoparticulate drug delivery systems show promise for improving OA
Area of Science:
- Natural product chemistry
- Pharmacology
- Nanotechnology
Background:
- Oleanolic acid (OA) is a triterpenoid with demonstrated anti-inflammatory, antitumor, antiviral, hepatoprotective, and antihyperlipidemic properties.
- Significant research advances in OA isolation, purification, modification, pharmacology, and toxicology have occurred.
- Limited clinical applications of OA are attributed to poor aqueous solubility, instability, and low bioavailability.
Purpose of the Study:
- To explore the potential of nanoparticulate drug delivery systems for improving Oleanolic acid (OA) formulations.
- To overcome the bioavailability and solubility challenges associated with OA for enhanced clinical utility.
Main Methods:
- Investigated nanoparticulate drug delivery systems as a strategy for formulating Oleanolic acid (OA).
- Focused on leveraging nanotechnology to enhance OA's dissolution rate and bioavailability.
Main Results:
- Nanoparticulate formulations significantly improve the dissolution rate of Oleanolic acid (OA).
- These systems enhance the bioavailability of Oleanolic acid (OA).
Conclusions:
- Nanoparticulate drug delivery offers a feasible method for creating effective Oleanolic acid (OA) formulations.
- This approach addresses key limitations of OA, paving the way for broader clinical applications.
